Mastopexy Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

The Mastopexy market studied is expected to grow with an estimated CAGR of 5.7% over the forecast period

As the COVID-19 pandemic progressed with new strains, the safety of ablative resurfacing lasers, micro-needling, and dermatological surgery procedures also seemed to be unsafe. Additionally, the slowing economy and reduced discretionary spending discourage customers from undergoing expensive cosmetic treatments, thus imposing practical restrictions. As per the Plastic Surgery Statistics Report from year 2020 states that total population of 87,051 patients underwent the mastopexy surgery in 2020.

Rising female geriatric population and growing demands for aesthetic procedures are estimated to drive the market growth during the forecast period.Increased healthcare expenditures along with the growing demands for outpatient surgeries is boosting the market growth. However, factors such as high cost for mastopexy followed by complications of the surgery are estimated to restrain the market growth during the forecast period.

Key Market Trends

Full mastopexy segment is Expected to dominate the market over the forecast period

Based on technique, the full mastopexy segment held a majority of the market share in terms of revenue. The full mastopexy procedure is performed in cases of breast sagginess, which is mainly observed in older women. Mastopexy also performed in breast cancer patients who undergo mastectomy and lumpectomy. During the procedure, the surgeons tend to remove cancerous tissues, which can led to breast reconstruction surgery. According to the American Cancer Society, it was estimated that 287,850 new cases of invasive breast cancer will be diagnosed in the United States in 2022. The high incidence of breast cancer can thus boost the market growth.

The mastopexy restores the volume and fullness of the breasts with or without the use of implants. As per the Aesthetic Society article published in April 2022, the annual statistics breast surgical procedures in 2021, accounted for 48% growth as compared to 2020. There were 365,000 breast augmentations performed in 2021 . Thus, the increase in the number of breast augmention will help to propel the demand for full mastopexy during the forecast period.

North America is projected to have a Prominent Growth Rate

North America region is the majority share contributor to the market revenue in 2021 and is expected to continue in the next years. Some of the factors driving regional growth include the rising demand for aesthetic procedures among women and increased disposable income. According to the American Society of Plastic Surgeons figures,the new and imaginative ways to shape the bodies are been developed, with minimally invasive cosmetic operations increasing nearly 200 percent since 2000. Breast enhancement is one of the top cosmetic surgical procedures performed in the NorthAmerica region.In the United States, breast cancer is one of the leading cancer types. According to the Breastcancer.org, updated in January 2022, about 1 in 8 women (about 13%) will develop invasive breast cancer over the lifetime.

The demand for cosmetic surgeries and procedures in the United States is very high among women, which is one of the significant factors for the growth of the mastopexy market in the region. For instance, according to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures performed in 2020 in the United States. Moreover, the total number was 193,073 breast augmentation procedures in 2020. In addition, the increasing prevalence of breast cancer in North America will also complement the growth of the breast implant market in the region. As per the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period.

Competitive Landscape

The mastopexy market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra, Inc,Ideal Implant Incorporated, Johnson & Johnson, Establishment Labs, POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebin SAS, Integra LifeSciences, and GC Aesthetics.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.